Search

So what exactly are you looking for? Let us know and we will help you find the best answer

Clear All

Marksans Pharma Ltd.

  • NSE: MARKSANS

  • BSE: 524404

  • Q
  • V
  • T
  • Strong Performer, Getting Expensive
58.50/100

Quality Score

High Financial Strength
30.83/100

Valuation Score

Mid Valuation
68.50/100

Technical Score

Technically Moderately Bullish
Broker Average Rating

0.00

Broker Average Rating

MFI

50.16

MFI is mid-range

50Day SMA Rs

45.65 Rs

Price above SMA 45.65

Quality score

58.50

High Financial Strength

30Day SMA Rs

49.37 Rs

Price below SMA-30

Broker Covering stock

0.00

0 Broker Covering stock

Broker 6M Target upgrade

0.00

0 Broker 6M Target upgrade

Broker 6M Target downgrade

0.00

0 Broker 6M Target downgrade

Momentum score

68.50

Technically Moderately Bullish

Price to Book Ratio

3.48

Above industry Median

Broker Reports in 1Yr

0.00

0 Broker Reports in 1Yr

TTM PE Ratio

13.02

Below industry Median

Broker 6M Reco upgrade

0.00

0 Broker 6M Reco upgrade

RSI

48.79

RSI is mid-range

Net Profit Qtr Cr

49.37 Cr

Above industry Median

AVG Broker Target

-100.00 %

No targets last year

Operating Revenues Qtr Cr

331.15 Cr

Above industry Median

MACD

0.97

MACD above Center

Valuation score

30.83

Mid Valuation

MACD Signal Line

1.12

MACD above Center

FII holding holding %

3.08 %

FII holding increased by 0.6%.

Promoter holding holding %

48.25 %

No change in Promoter holding

MF holding holding %

0.00 %

MF holding holding

Broker 6M Reco downgrade

0.00

0 Broker 6M Reco downgrade

100Day SMA Rs

36.91 Rs

Price above SMA 36.91

Institutions holding holding %

3.95 %

Institutions holding increased by 0.53%.

AVG Broker Target

0.00 Rs

No targets last year

200Day SMA Rs

27.20 Rs

Price above SMA 27.2

NSE MARKSANS
46.75
  • 47.65 Close
  • 48.65 Open
  • 5.58 Lk Volume
Today Low/High
Low 46.60
High 49.00
52 Week Low/High
24-03-2020 9.85
20-08-2020 57.10

Peer Comparison

All values except ratios in INR(Crores)

Stock Name Current Price Rs PE TTM Price To Earnings Market Capitalization In Cr Dividend Yield 1yr % Net Profit Qtr Cr Net Profit Annual Growth YoY % Operating Revenues Qtr Cr Revenue Growth Qtr YoY Price To Book Value
Marksans Pharma Ltd. 46.95 13.01 1921.71 0.21 49.36 0 331.15 35.14 3.47
Sun Pharmaceutical Industries Ltd. 504.35 473.43 121008.69 0.79 -2429.81 0 7585.25 -9.43 2.46
Dr. Reddy's Laboratories Ltd. 5126 44.91 85194.12 0.48 586.9 0 4426.5 14.72 5.46
Divi's Laboratories Ltd. 3179.35 52.87 84395.84 0.5 492.06 0 1730.47 48.8 11.54
Cipla Ltd. 768.55 37.6 61964.34 0.52 571.42 0 4346.16 8.95 3.85
Aurobindo Pharma Ltd. 785 15.29 45993.15 0.54 792.68 0 5924.78 8.81 2.73
Lupin Ltd. 1013.5 -98.27 45921.68 0.59 108.14 0 3527.86 -20.16 3.65
Torrent Pharmaceuticals Ltd. 2676 40.07 45288.62 1.19 321 0 2056 1.68 9.39